Loading…
enVVeno Medical Corporation is projected to rise to $11.99 by 2027, a +9% move from its current price of $11.00. NVNO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $10.65 | $11.01 | $11.38 | +0.11% |
| Jul 13 | $10.52 | $11.02 | $11.55 | +0.21% |
| Jul 14 | $10.42 | $11.04 | $11.69 | +0.32% |
| Jul 15 | $10.34 | $11.05 | $11.80 | +0.42% |
| Jul 16 | $10.27 | $11.06 | $11.91 | +0.53% |
| Jul 17 | $10.21 | $11.07 | $12.01 | +0.64% |
| Jul 18 | $10.15 | $11.08 | $12.10 | +0.74% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.15 | $11.08 | $12.10 | +0.74% |
| Week 2 | $9.86 | $11.16 | $12.64 | +1.49% |
| Week 3 | $9.66 | $11.25 | $13.09 | +2.25% |
| Week 4 | $9.51 | $11.33 | $13.50 | +3.01% |
| Week 5 | $9.38 | $11.42 | $13.89 | +3.78% |
| Week 6 | $9.28 | $11.50 | $14.26 | +4.55% |
| Week 7 | $9.19 | $11.59 | $14.61 | +5.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
enVVeno Medical Corporation is a healthcare company focused on medical devices that develop bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. Its lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. The VenoValve is implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh.
The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021.
enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
enVVeno Medical Corporation trades as NVNO in the healthcare sector. The current price is $11.37 with a market cap of $7.59M and a rank of 5190. The forecast suggests a bullish price trajectory over time, with the average price target rising across years and a clear path to substantial upside by 2050.
For example, the 2030 average target is $20.57, the 2040 average target is $42.78, and the 2050 average target is $85.42, with the 2050 max reaching $192.65 and an overall long-range ROI of 651.3%.
Overall, the outlook reflects potential upside over the extended horizon, though individual year results vary and are not guarantees. Investors should consider the projected ranges and note that forecasts depict estimates rather than certainties.
A major floor 15.8% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key NVNO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVNO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.12 | Sell | $11.13 | Sell |
| MA 10 | $11.01 | Sell | $11.01 | Sell |
| MA 20 | $10.69 | Buy | $10.84 | Buy |
| MA 50 | $10.53 | Buy | $10.80 | Buy |
| MA 100 | $10.83 | Buy | $12.82 | Sell |
| MA 200 | $14.28 | Sell | $26.03 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.87 | Neutral |
| Stoch RSI (14) | 94.35 | Sell |
| CCI (20) | 104.50 | Buy |
| Williams %R (14) | -0.63 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 16.04 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 99.37 | Sell |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 0.41 | Buy |
| Ultimate (7,14,28) | 71.32 | Sell |
| Momentum (10) | 0.31 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 11.18 | Sell |
| ADX (14) | 10.39 | Neutral |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60 and a price showing upside momentum. The 50-day simple moving average (SMA50) sits at $10.77 and the 200-day simple moving average (SMA200) at $15.30, indicating a mixed longer-term trend with near-term strength.
Key levels show support at $9.32 and resistance at $11.37. The 30-day range spans from $8.54 to $15.14, highlighting a broad trading window in the near term. While sentiment remains bullish, traders should monitor how price interacts with the $11.37 resistance and the $9.32 support as the range evolves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.67 | $11.00 | $15.46 | 0% | Neutral | |
| $9.35 | $11.99 | $16.36 | +9% | Neutral | |
| $11.08 | $14.70 | $20.97 | +34% | Bullish | |
| $14.05 | $19.19 | $28.30 | +74% | Bullish | |
| $13.13 | $18.40 | $27.92 | +67% | Bullish | |
| $12.80 | $18.37 | $28.57 | +67% | Bullish | |
| $13.47 | $19.76 | $31.42 | +80% | Bullish | |
| $12.94 | $19.38 | $31.43 | +76% | Bullish | |
| $15.51 | $23.69 | $39.13 | +115% | Bullish | |
| $17.99 | $28.00 | $47.04 | +155% | Bullish | |
| $19.75 | $33.55 | $60.48 | +205% | Bullish | |
| $35.37 | $70.13 | $139.96 | +538% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.67 | $11.00 | $13.28 | +0.00% |
| August 2026 | $9.91 | $11.76 | $14.39 | +6.94% |
| September 2026 | $10.12 | $12.12 | $15.02 | +3.00% |
| October 2026 | $9.78 | $11.80 | $14.79 | -2.63% |
| November 2026 | $9.74 | $11.82 | $14.96 | +0.21% |
| December 2026 | $9.92 | $12.11 | $15.46 | +2.42% |
Click any year to see its month-by-month NVNO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NVNO to range from $8.67 to $15.46 through 2026. The $11.00 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The NVNO price prediction for 2027 points to an average of $11.99 (low $9.35, high $16.36) — a potential gain of +9% on today's $11.00. A consolidation phase looks the most probable path here.
In 2028, NVNO is projected to trade between $11.08 and $20.97, averaging $14.70 — a potential gain of +34% from today's $11.00. That is up +23% on the projected 2027 average. Momentum favours further upside here.
enVVeno Medical Corporation's 2029 outlook centres on $19.19, within a $14.05 to $28.30 range. That is up +31% on the projected 2028 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, NVNO could reach as high as $27.92, with a base case around $18.40 and support toward $13.13 — roughly +67% from $11.00. Momentum favours further upside here.
Expect NVNO to range from $12.80 to $28.57 through 2031. The $18.37 average target implies a +67% move from current prices. That is 0% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The NVNO price prediction for 2032 points to an average of $19.76 (low $13.47, high $31.42) — a potential gain of +80% on today's $11.00. Momentum favours further upside here.
In 2033, NVNO is projected to trade between $12.94 and $31.43, averaging $19.38 — a potential gain of +76% from today's $11.00. That is -2% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
enVVeno Medical Corporation's 2034 outlook centres on $23.69, within a $15.51 to $39.13 range. That is up +22% on the projected 2033 average. That marks a +115% change versus current levels. Momentum favours further upside here.
By 2035, NVNO could reach as high as $47.04, with a base case around $28.00 and support toward $17.99 — roughly +155% from $11.00. Buyers look set to stay in control over this stretch.
Expect NVNO to range from $19.75 to $60.48 through 2040. The $33.55 average target implies a +205% move from current prices. That is up +20% on the projected 2035 average. Momentum favours further upside here.
The NVNO price prediction for 2050 points to an average of $70.13 (low $35.37, high $139.96) — a potential gain of +538% on today's $11.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVNO today (≈ 90.909091 NVNO) could be worth
$6,375.24
+$5,375.24 (+538%) by 2050 · US Dollar
Based on the average projected NVNO price of $70.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVNOwould be worth at today's price.
$1,000 invested in NVNO on Jul 10, 2025 (≈ 6.613757 NVNO) would be worth
$72.75
-$927.25 (-92.7%) today · 0.07× · US Dollar
Based on a NVNO entry price of $151.2 vs. today's $11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.11 | $990.1 | -1.0% |
| 1 month ago | $10.27 | $1,071.08 | +7.1% |
| 3 months ago | $11.05 | $995.48 | -0.5% |
| 6 months ago | $11.76 | $935.37 | -6.5% |
| 1 year ago | $151.2 | $72.75 | -92.7% |
| All time (5.0y) ago | $221.55 | $49.65 | -95.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVNO forecast.
Our base-case forecast reaches $22.00 around 2034.
Implied market cap at $22.00: $14.69M
The multi-year forecast shows growing upside across the years with notable milestones. In 2026, the min is $8.67, the avg is $11.37, the max is $16.73, ROI is 0, and sentiment is Neutral. In 2027, the min is $9.41, the avg is $12.53, the max is $17.96, ROI is 10.2, sentiment Neutral.
The 2028 forecast places the avg at $17.23 (min $12.34, max $26.04) with ROI 51.5 and a Bullish stance.
By 2029 the avg reaches $22.71 (min $15.64, max $35.77) with ROI 99.8 and Bullish sentiment. In 2030 the avg is $20.57 (min $13.67, max $33.54) with ROI 80.9 and Bullish. The trajectory continues with 2031 at $21.07 avg (min $13.54, max $35.39) ROI 85.3 and Bullish, and 2032 at $22.76 avg (min $14.17, max $39.25) ROI 100.2 and Bullish.
2033 shows $21.33 avg (min $12.89, max $37.68) ROI 87.6 Bullish.
Further out, 2034 carries an avg of $29.03 (min $17.05, max $52.41) ROI 155.3 Bullish, and 2035 carries an avg of $34.48 (min $19.70, max $63.54) ROI 203.3 Bullish. The forecast for 2040 shows an avg of $42.78 (min $21.44, max $85.69) ROI 276.3 Bullish, and by 2050 the avg is $85.42 (min $38.44, max $192.65) ROI 651.3 Bullish. Overall, the long-run view is bullish, with upside potential evident across multiple milestones, but these figures are estimates and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $13.67, an avg of $20.57, and a max of $33.54, with an ROI of 80.9% and a Bullish sentiment.
Forecasts show upside potential across several years, including a 2029 ROI of 99.8% and a 2034 ROI of 155.3%, with a Bullish sentiment in later years. These are estimates and not guarantees.
Yes. The 2050 forecast max is $192.65, which exceeds $100.
Min $8.67, avg $11.37, max $16.73, ROI 0, sentiment Neutral.
enVVeno Medical Corporation Community Discussion
0Share your enVVeno Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.